Measles, also known as rubeola, is a highly contagious viral infection that has been a significant public health concern for centuries. Despite the availability of effective vaccines, measles continues to cause outbreaks worldwide, particularly in regions with low vaccination coverage. Understanding the nature of measles, its transmission, symptoms, complications, prevention, and global impact is essential to control and eventually eliminate this preventable disease.
Historical Background
Measles has been documented for thousands of years, with references dating back to ancient Egyptian and Indian texts. The disease became more widely recognized in the 9th century, and its association with a specific virus was established in the 20th century. The development of the measles vaccine in the 1960s marked a turning point in disease control, significantly reducing global morbidity and mortality. However, outbreaks still occur due to gaps in immunization programs.
Virology and Pathogenesis
Measles is caused by the measles virus, a single-stranded, negative-sense RNA virus belonging to the genus Morbillivirus within the Paramyxoviridae family. The virus is primarily transmitted via respiratory droplets when an infected person coughs or sneezes. It can remain infectious in the air or on surfaces for up to two hours.
Once inhaled, the virus infects the respiratory mucosa and then spreads via the lymphatic system and bloodstream, leading to viremia. The virus targets immune cells and epithelial tissues, causing widespread systemic infection. The immune response to the virus accounts for many of the clinical features observed.
Epidemiology
Measles is one of the most contagious diseases known, with a basic reproduction number (R0) between 12 and 18. This means a single infected individual can potentially infect 12 to 18 susceptible people in a completely susceptible population. Historically, measles was endemic worldwide, but widespread vaccination has dramatically reduced cases.
Despite successes, measles remains endemic in many parts of Africa, Asia, and the Pacific, with occasional outbreaks elsewhere due to vaccine hesitancy or gaps in immunization coverage. The World Health Organization (WHO) estimates that measles caused over 100,000 deaths globally in 2019, although this number has been decreasing over the past decades.
Clinical Features
The incubation period for measles is typically 10-14 days after exposure. The disease progresses through several stages:
- Prodromal Phase (2-4 days):
- High fever (up to 40°C or 104°F)
- Cough
- Coryza (runny nose)
- Conjunctivitis (red, watery eyes)
- Koplik spots: small white lesions on the buccal mucosa, considered pathognomonic
- Exanthem Phase:
- Maculopapular rash appears 3-5 days after initial symptoms
- The rash typically begins behind the ears and spreads downward to the face, neck, trunk, and extremities
- The rash lasts for about 5-6 days and fades in the same order it appears
- Recovery Phase:
- Fever subsides
- Healing of rash with desquamation
- In some cases, complications may develop during or after this phase
Complications
Measles can lead to severe complications, especially in young children, pregnant women, and immunocompromised individuals:
- Encephalitis: inflammation of the brain, occurs in approximately 1 in 1,000 cases, leading to neurological deficits or death
- Pneumonia: the most common cause of death in measles cases
- Otitis media: middle ear infections causing hearing loss
- Diarrhea: leading to dehydration
- Subacute sclerosing panencephalitis (SSPE): a rare, fatal degenerative neurological disorder occurring years after infection
- Pregnancy complications: miscarriage, premature birth, or low birth weight
Diagnosis
Diagnosis of measles is primarily clinical, based on symptoms and characteristic rash, especially in unvaccinated individuals or during outbreaks. Laboratory confirmation can be achieved through:
- Serology: detection of measles-specific IgM antibodies
- Polymerase chain reaction (PCR): detecting viral RNA from respiratory secretions or blood
- Virus isolation: less commonly used due to complexity and time
Prevention
Vaccination remains the cornerstone of measles prevention. The measles-mumps-rubella (MMR) vaccine is highly effective and safe. The recommended immunization schedule typically includes:
- Two doses of MMR vaccine:
- First dose at 12-15 months of age
- Second dose at 4-6 years of age
In some countries, catch-up campaigns target older children and adults who missed vaccination.
Herd Immunity: Achieving high vaccination coverage (at least 95%) is crucial to establish herd immunity and prevent outbreaks. WHO and UNICEF promote immunization campaigns, surveillance, and public education to close immunity gaps.
Treatment
There is no specific antiviral treatment for measles. Management is supportive:
- Adequate hydration
- Rest
- Fever reducers (e.g., acetaminophen)
- Treatment of secondary bacterial infections
- Vitamin A supplementation, which has been shown to reduce morbidity and mortality, especially in children with vitamin A deficiency
Global Challenges and Elimination Efforts
Despite the availability of vaccines, measles continues to pose challenges:
- Vaccine hesitancy and misinformation
- Inadequate healthcare infrastructure
- Conflict zones and displaced populations
- COVID-19 pandemic disruptions affecting immunization programs
Global efforts aim for measles elimination in regions and eventual eradication worldwide. Multiple countries have declared themselves free of endemic measles, but sporadic outbreaks highlight the need for sustained immunization efforts.
Measles remains a preventable yet persistent public health threat. Its high contagiousness, potential for severe complications, and the availability of effective vaccines underscore the importance of comprehensive immunization strategies. Continued vigilance, vaccination coverage, and global cooperation are essential to eliminate measles and protect future generations from this devastating disease.
References
- World Health Organization. (2020). Measles Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/measles
- Centers for Disease Control and Prevention. (2021). Measles (Rubeola). https://www.cdc.gov/measles/index.html
- Moss, W. J. (2017). Measles. The Lancet, 390(10111), 2490-2502.
- Patel, M. K., et al. (2019). Progress Toward Regional Measles Elimination — Worldwide, 2000–2018. MMWR Morb Mortal Wkly Rep, 68(48), 1105–1111.